Cargando…
Blood pressure increase after Pfizer/BioNTech SARS-CoV-2 vaccine
Autores principales: | Zappa, Martina, Verdecchia, Paolo, Spanevello, Antonio, Visca, Dina, Angeli, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206586/ https://www.ncbi.nlm.nih.gov/pubmed/34158234 http://dx.doi.org/10.1016/j.ejim.2021.06.013 |
Ejemplares similares
-
Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster
por: Landsberg, Hannah E., et al.
Publicado: (2022) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021) -
Pfizer-BioNTech COVID-19 vaccine safe in children
Publicado: (2022) -
Tachycardia following Pfizer-BioNTech COVID-19 vaccine
por: Martins-Filho, Paulo Ricardo
Publicado: (2023)